Iqbal Hussain's most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 6,000 Ordinary Shares done at an average price of $5.8 . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 15 Jul 2025 | 6,000 | 111,386 | - | 5.8 | 35,040 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 6,000 | 285,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 14.93 per share. | 15 Jul 2025 | 6,000 | 105,386 | - | 14.9 | 89,567 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 12,000 | 291,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 14.02 per share. | 24 Jun 2025 | 12,000 | 105,386 | - | 14.0 | 168,218 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 24 Jun 2025 | 12,000 | 117,386 | - | 5.8 | 70,080 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Hussain Iqbal | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 311 | 303,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Hussain Iqbal | General Counsel | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 01 May 2025 | 311 | 105,386 | - | 14 | 4,354 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 01 May 2025 | 311 | 105,697 | - | 5.8 | 1,816 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 3,609 | 305,950 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 25 Apr 2025 | 3,609 | 105,386 | - | 14 | 50,526 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 25 Apr 2025 | 3,609 | 108,995 | - | 5.8 | 21,077 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 2,080 | 303,870 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 14.01 per share. | 25 Apr 2025 | 2,080 | 105,386 | - | 14.0 | 29,132 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 25 Apr 2025 | 2,080 | 107,466 | - | 5.8 | 12,147 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 6,000 | 309,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 17 Mar 2025 | 6,000 | 105,386 | - | 16.4 | 98,697 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 17 Mar 2025 | 6,000 | 111,386 | - | 5.8 | 35,040 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 18 Feb 2025 | 6,000 | 111,386 | - | 5.8 | 35,040 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 6,000 | 315,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 18 Feb 2025 | 4,612 | 106,774 | - | 15.9 | 73,396 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 18 Feb 2025 | 1,388 | 105,386 | - | 17.1 | 23,669 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 175,000 | 175,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.92 per share. | 01 Feb 2025 | 12,879 | 105,386 | - | 16.9 | 217,913 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 15 Jan 2025 | 6,000 | 124,265 | - | 5.8 | 35,040 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 15.29 per share. | 15 Jan 2025 | 6,000 | 118,265 | - | 15.3 | 91,740 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 6,000 | 321,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.35 per share. | 31 Dec 2024 | 7,520 | 118,265 | - | 16.4 | 122,952 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 16.39 per share. | 16 Dec 2024 | 77,705 | 125,785 | - | 16.4 | 1,273,756 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 16 Dec 2024 | 6,000 | 203,490 | - | 5.8 | 35,040 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 6,000 | 327,559 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.79 per share. | 30 Sep 2024 | 7,520 | 197,490 | - | 15.8 | 118,741 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 30 Jun 2024 | 7,520 | 205,010 | - | 9.0 | 67,906 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.30 per share. | 31 Mar 2024 | 7,520 | 212,530 | - | 11.3 | 84,976 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 170,000 | 170,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 42,500 | 227,935 | - | 0 | Ordinary Shares | |
| Centessa Pharmaceuticals p... | Iqbal Hussain | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 01 Feb 2024 | 7,885 | 220,050 | - | 8.2 | 64,578 | Ordinary Shares |